4//SEC Filing
Oki Mark K 4
Accession 0000912282-23-000296
CIK 0001385818other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:28 PM ET
Size
5.3 KB
Accession
0000912282-23-000296
Insider Transaction Report
Form 4
Oki Mark K
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-08-11+13,000→ 13,000 totalExercise: $1.73Exp: 2033-08-12→ Common Shares (13,000 underlying)
Footnotes (1)
- [F1]The options vest as follows: 1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001491847
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:28 PM ET
- Size
- 5.3 KB